Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · IEX Real-Time Price · USD
7.88
-0.01 (-0.13%)
At close: Jul 19, 2024, 4:00 PM
7.91
+0.03 (0.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $196.03M in the twelve months ending March 31, 2024, with 26.48% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $51.11M with 21.12% year-over-year growth. In the year 2023, Treace Medical Concepts had annual revenue of $187.12M with 31.92% growth.
Revenue (ttm)
$196.03M
Revenue Growth
+26.48%
P/S Ratio
2.49
Revenue / Employee
$379,905
Employees
516
Market Cap
488.62M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
Dec 31, 2019 | 39.42M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sharecare | 419.82M |
biote | 187.32M |
Heron Therapeutics | 132.10M |
Jin Medical International | 19.82M |
Fate Therapeutics | 6.48M |
Fulcrum Therapeutics | 2.51M |
Oculis Holding AG | 995.46K |
TMCI News
- 3 days ago - Treace to Report Second Quarter 2024 Financial Results on August 6, 2024 - GlobeNewsWire
- 6 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI - Accesswire
- 7 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Treace Medical Concepts, Inc. - TMCI - Accesswire
- 7 weeks ago - Treace to Present at Truist Securities MedTech Conference - GlobeNewsWire
- 2 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga
- 2 months ago - Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI) - Business Wire
- 3 months ago - Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour - GlobeNewsWire
- 3 months ago - Treace to Present at Bank of America Health Care Conference - GlobeNewsWire